GlassScriptPhysician profile
Seth Martin
NPI 1801355862
$1,712.45
in general payments reported to CMS, 2019-2025
14 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 75% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $38.64 · 2024: $620 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.37 | 2023-2025 | |
| Organogenesis INC. | $428.43 | 2024-2025 | Novachor, Affinity, Cygnus Dual |
| Medtronic, INC. | $161.21 | 2025 | Abre |
| Kerecis Limited | $125.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Janssen Biotech, INC. | $104.18 | 2025 | Tremfya |
| Organon LLC | $90.87 | 2025 | Hadlima |
| Sun Pharmaceutical Industries INC. | $86.16 | 2025 | |
| Incyte Corporation | $53.80 | 2024-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $51.35 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $47.33 | 2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $32.74 | 2025 | |
| Smith+Nephew, INC. | $26.76 | 2024 | Grafix Xc |
| Leo Pharma INC. | $22.35 | 2024 | Adbry |
| Lilly USA, LLC | $14.26 | 2025 | Taltz, Ebglyss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.